Systemic thrombolysis for cerebral venous and dural sinus thrombosis: a systematic review

L D Viegas1, E Stolz, P Canhão

  • 1Department of Neurosciences (Neurology), Hospital de Santa Maria, University of Lisbon, Lisbon, Portugal.

Insights

Systemic thrombolysis for cerebral venous thrombosis (CVT) showed an 88% independence rate but carried bleeding risks. Efficacy remains unproven due to limited data, though outcomes mirror previous reviews.

Area of Science:

  • Neurology
  • Vascular Neurology
  • Interventional Neurology

Background:

  • Cerebral venous and dural sinus thrombosis (CVT) management often considers thrombolytics for patients worsening on anticoagulation.
  • Assessing the role of systemic thrombolysis in improving outcomes for CVT is crucial.

Purpose of the Study:

  • To systematically review and analyze published data on systemic thrombolysis use in CVT.
  • To evaluate the efficacy and safety profile of thrombolytic therapy in CVT patients.

Main Methods:

  • A comprehensive PubMed search and reference list review were conducted.
  • Data from the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) were incorporated.
  • Patient outcomes were assessed using the modified Rankin Scale (mRS) at last follow-up.

Main Results:

  • 16 reports involving 26 CVT patients were analyzed; no randomized trials were found.
  • Urokinase was the most common agent; intracranial hemorrhage occurred in 11.5% and serious bleeding in 11.5% (2 deaths).
  • 88% of patients achieved independence (mRS 0-2), with a survival rate of 92.3%.

Conclusions:

  • Systemic thrombolysis in CVT resulted in high functional independence but was associated with significant bleeding risks.
  • The efficacy of systemic thrombolysis for acute CVT remains uncertain due to small sample sizes and lack of control groups.
  • Bleeding complications necessitate careful consideration of the risks versus benefits in clinical practice.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
469
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
822
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
415
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
20